Sudan’s war forces diabetics to choose between insulin and food
The ongoing conflict in Sudan has driven up the cost of insulin and other medicines, leaving chronically ill patients to decide between treatment and basic necessities.
Since the war erupted in April 2023, Sudanese civilians with chronic conditions have faced a deteriorating health landscape. Diabetics such as Hasanat al-Rashid travel between hospitals and now purchase insulin vials for 17,000 Sudanese pounds, adding a monthly ice cost of 180,000 pounds to preserve the drug. Hypertensive patients like Fatima Adam, previously covered by the National Health Insurance Fund, now pay full prices, with a month’s supply costing 160,000 pounds.
The pharmaceutical sector has lost an estimated $500 million in stock and infrastructure, and only eight of thirty factories have resumed operations, increasing reliance on costly imports. The Sudanese pound’s devaluation—from roughly 600 to 9,300 pounds per dollar on the black market—has amplified these price hikes, leaving many unable to afford essential medicines. Pharmacists report selling drugs at break-even prices, further straining supply. Patients fear running out of medication, which could lead to life-threatening complications.
Why it matters
It shows how war and economic collapse can cripple access to life-saving treatment for vulnerable populations.
In this story
